Challenges of COVID‐19 pandemic: Dermatologist’s perspective from Nepal

In our part, over‐the‐counter (OTC) treatments are easily available. Since COVID has increased the misuse of drugs with a narrow therapeutic index like methotrexate, chronic dermatology patients may end up with life‐threatening adverse effects in the future. Since we were not at all prepared for thi...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Dermatology 2020-12, Vol.59 (12), p.1537-1538
Main Authors: Marahatta, Suchana, Marahatta, Sujan Babu
Format: Article
Language:English
Subjects:
Betacoronavirus - pathogenicity
Communicable Disease Control - instrumentation
Communicable Disease Control - standards
Communicable Disease Control - trends
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
Coronavirus Infections - virology
COVID-19
Dermatitis, Contact - etiology
Dermatitis, Contact - prevention & control
Dermatitis, Occupational - etiology
Dermatitis, Occupational - prevention & control
Dermatologists - education
Dermatologists - standards
Dermatology - education
Dermatology - standards
Dermatology - trends
Education, Medical - standards
Education, Medical - trends
Hand Hygiene - standards
Humans
Infectious Disease Transmission, Patient-to-Professional - prevention & control
Infectious Disease Transmission, Professional-to-Patient - prevention & control
Nepal - epidemiology
Pandemics
Pandemics - prevention & control
Personal Protective Equipment - adverse effects
Personal Protective Equipment - standards
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
Pneumonia, Viral - virology
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In our part, over‐the‐counter (OTC) treatments are easily available. Since COVID has increased the misuse of drugs with a narrow therapeutic index like methotrexate, chronic dermatology patients may end up with life‐threatening adverse effects in the future. Since we were not at all prepared for this type of pandemic with infrastructure and electronic record‐keeping systems, it has become very difficult even to trace out our previous patients for inquiry and follow‐up. [...]we need to upgrade many technical aspects before opting for it for future use. Since visual assessment can give maximum clue for the diagnosis, dermatologists are lucky enough to use teledermatology more easily as compared to other specialties.
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.15236